Label Changes for:

Neurontin (gabapentin) capsules, tablets, and oral solution

March 2011

Changes have been made to the ADVERSE REACTIONS sections of the safety label.

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – March 2011

 

 

ADVERSE REACTIONS

Postmarketing and Other Experience
  • breast enlargement
Hide
(web1)